Literature DB >> 22515105

Preparation and characterization of monensin loaded PLGA nanoparticles: in vitro anti-malarial activity against Plasmodium falciparum.

Ranu Surolia1, Manendra Pachauri, Prahlad Chandra Ghosh.   

Abstract

PLGA nanoparticles loaded with monensin (carboxylic ionophore) were prepared by emulsion solvent evaporation method using PLGA of molecular weight (Mw.) 19000 and 110000 Da. The nanoparticles were characterized by applying dynamic light scattering (DLS), atomic force microscopy (AFM), differential scanning calorimetry (DSC) and Fourier transformed infrared spectroscopy (FTIR). Negatively charged and spherical smooth surfaced nanoparticles of size range between 147-167 nm were obtained. The nanoparticles of monensin-PLGA showed no chemical interaction between monensin and the polymer molecules. The release kinetics in vitro studies exhibited biphasic release profile characterized by an initial fast release followed by a slower release. The antimalarial efficacy of monensin-PLGA nanoparticles was also examined. Monensin loaded in nanoparticles was 10-fold more effective in inhibiting the growth of P. falciparum in vitro as compared to free monensin. The antimalarial efficacy of monensin-PLGA nanoparticles was significantly dependent on the Mw. of the polymer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22515105     DOI: 10.1166/jbn.2012.1366

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  8 in total

1.  Preparation and Characterization of Nanosuspension of Aprepitant by H96 Process.

Authors:  Sunethra Kalvakuntla; Mangesh Deshpande; Zenab Attari; Koteshwara Kunnatur B
Journal:  Adv Pharm Bull       Date:  2016-03-17

2.  Evaluation of Surfactants-Assisted Folic Acid-Loaded Pectin Submicrospheres: Characterization and Hemocompatibility Assay.

Authors:  J B Varuna Kumara; N R Ravikumara; Basavaraj Madhusudhan
Journal:  Indian J Clin Biochem       Date:  2016-03-01

3.  Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity.

Authors:  Sarah D'Alessandro; Yolanda Corbett; Denise P Ilboudo; Paola Misiano; Nisha Dahiya; Solomon M Abay; Annette Habluetzel; Romualdo Grande; Maria R Gismondo; Koen J Dechering; Karin M J Koolen; Robert W Sauerwein; Donatella Taramelli; Nicoletta Basilico; Silvia Parapini
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

4.  Purification and characterization of a novel and robust L-asparaginase having low-glutaminase activity from Bacillus licheniformis: in vitro evaluation of anti-cancerous properties.

Authors:  Richi V Mahajan; Vinod Kumar; Vinoth Rajendran; Saurabh Saran; Prahlad C Ghosh; Rajendra Kumar Saxena
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

5.  Jacobsen catalyst as a cytochrome P450 biomimetic model for the metabolism of monensin A.

Authors:  Bruno Alves Rocha; Anderson Rodrigo Moraes de Oliveira; Murilo Pazin; Daniel Junqueira Dorta; Andresa Piacezzi Nascimento Rodrigues; Andresa Aparecida Berretta; Ana Paula Ferranti Peti; Luiz Alberto Beraldo de Moraes; Norberto Peporine Lopes; Stanislav Pospíšil; Paul Jonathan Gates; Marilda das Dores Assis
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

6.  A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.

Authors:  Tarek Abdelnapy Ahmed; Bader M Aljaeid
Journal:  Int J Nanomedicine       Date:  2017-03-08

7.  The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma.

Authors:  Nada Muhamad; Tullayakorn Plengsuriyakarn; Chuda Chittasupho; Kesara Na-Bangchang
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01

Review 8.  Review of the Current Landscape of the Potential of Nanotechnology for Future Malaria Diagnosis, Treatment, and Vaccination Strategies.

Authors:  Arnau Guasch-Girbau; Xavier Fernàndez-Busquets
Journal:  Pharmaceutics       Date:  2021-12-17       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.